 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Spero Therapeutics Inc. (SPRO)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-07-05 Sale | 2018-07-06 9:41 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 4,676 | $17.63 | $82,437 | 65,817 (Direct) | View |
| 2018-07-05 Sale | 2018-07-06 9:44 pm | Spero Therapeutics Inc. | SPRO | Sendek Joel CFO | 2,000 | $17.5 | $35,000 | 15,181 (Direct) | View |
| 2018-07-05 Sale | 2018-07-06 9:45 pm | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 4,000 | $17.5 | $70,000 | 1,500 (Direct) | View |
| 2018-07-17 Purchase | 2018-07-17 5:01 pm | Spero Therapeutics Inc. | SPRO | GLAXOSMITHKLINE PLC 10% Owner | 80,000 | $12.5 | $1,000,000 | 1,934,006 (Indirect) | View |
| 2020-06-22 Sale | 2020-06-29 9:21 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 17,180 | $14.3 | $245,699 | 65,817 (Direct) | View |
| 2020-07-07 Sale | 2020-07-09 6:48 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 3,047 | $14.29 | $43,552 | 65,817 (Direct) | View |
| 2020-09-08 Sale | 2020-09-10 9:51 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 774 | $14.25 | $11,030 | 65,817 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-12-13 Option Award | 2017-12-15 4:05 pm | N/A 2027-12-12 | Spero Therapeutics Inc. | SPRO | Parr Thomas R JR Chief Scientific Officer | 36,134 | $11.63 | 36,134 (Direct) | View |
| 2017-12-13 Option Award | 2017-12-15 4:06 pm | N/A 2027-12-12 | Spero Therapeutics Inc. | SPRO | Sendek Joel CFO | 27,795 | $11.63 | 27,795 (Direct) | View |
| 2017-12-13 Option Award | 2017-12-15 4:07 pm | N/A 2027-12-12 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 62,540 | $11.63 | 62,540 (Direct) | View |
| 2018-01-04 Option Award | 2018-01-05 10:11 am | N/A 2028-01-03 | Spero Therapeutics Inc. | SPRO | Melnick David A. Chief Medical Officer | 135,000 | $12.14 | 135,000 (Direct) | View |
| 2018-03-30 Option Award | 2018-03-30 5:30 pm | N/A 2028-03-30 | Spero Therapeutics Inc. | SPRO | SOUTHWELL DAVID P Director | 12,146 | $14.25 | 12,146 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 8:00 pm | N/A 2028-06-05 | Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director | 6,073 | $11.54 | 6,073 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 8:00 pm | N/A 2028-06-05 | Spero Therapeutics Inc. | SPRO | Deshpande Milind Director | 6,073 | $11.54 | 6,073 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 8:01 pm | N/A 2028-06-05 | Spero Therapeutics Inc. | SPRO | Breum Casper Director | 6,073 | $11.54 | 6,073 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 8:01 pm | N/A 2028-06-05 | Spero Therapeutics Inc. | SPRO | SOUTHWELL DAVID P Director | 6,073 | $11.54 | 6,073 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 8:01 pm | N/A 2028-06-05 | Spero Therapeutics Inc. | SPRO | FORMELA JEAN FRANCOIS Director | 6,073 | $11.54 | 6,073 (Direct) | View |
| 2018-06-05 Option Award | 2018-06-06 8:02 pm | N/A 2028-06-05 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 6,073 | $11.54 | 6,073 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:41 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 3,076 | $5.9 | 65,817 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:41 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 1,600 | $5.9 | 65,817 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:41 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 3,076 | $5.9 | 65,817 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:41 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 1,600 | $5.9 | 65,817 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:44 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Sendek Joel CFO | 2,000 | $5.9 | 15,181 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:44 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Sendek Joel CFO | 2,000 | $5.9 | 15,181 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:45 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 4,000 | $5.9 | 1,500 (Direct) | View |
| 2018-07-05 Exercise | 2018-07-06 9:45 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 4,000 | $5.9 | 1,500 (Direct) | View |
| 2018-09-21 Option Award | 2018-09-21 5:38 pm | N/A 2028-09-21 | Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director | 12,146 | $10.25 | 12,146 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 7:12 pm | N/A 2029-01-02 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 180,000 | $6.26 | 180,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 7:16 pm | N/A 2029-01-02 | Spero Therapeutics Inc. | SPRO | Sendek Joel CFO | 65,000 | $6.26 | 65,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 7:18 pm | N/A 2029-01-02 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 65,000 | $6.26 | 65,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 7:20 pm | N/A 2029-01-02 | Spero Therapeutics Inc. | SPRO | Melnick David A. Chief Medical Officer | 65,000 | $6.26 | 65,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-02 7:23 pm | N/A 2029-01-02 | Spero Therapeutics Inc. | SPRO | Parr Thomas R JR Chief Scientific Officer | 35,000 | $6.26 | 35,000 (Direct) | View |
| 2019-03-29 Option Award | 2019-03-29 7:29 pm | N/A 2029-03-29 | Spero Therapeutics Inc. | SPRO | Smith Cynthia Director | 12,146 | $12.81 | 12,146 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:45 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director | 6,073 | $10.67 | 6,073 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:47 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | Deshpande Milind Director | 6,073 | $10.67 | 6,073 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:48 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | FORMELA JEAN FRANCOIS Director | 6,073 | $10.67 | 6,073 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:50 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 6,073 | $10.67 | 6,073 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:53 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director | 6,073 | $10.67 | 6,073 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-05 6:54 pm | N/A 2029-06-05 | Spero Therapeutics Inc. | SPRO | Smith Cynthia Director | 6,073 | $10.67 | 6,073 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:03 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | Deshpande Milind Director | 5,408 | $6.47 | 5,408 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:05 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director | 5,408 | $6.47 | 5,408 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:06 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | FORMELA JEAN FRANCOIS Director | 5,408 | $6.47 | 5,408 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 7:09 pm | N/A 2030-01-02 | Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director | 2,704 | $6.47 | 2,704 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:28 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Development Officer | 55,000 | $9.34 | 55,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:32 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Larkin Cristina COO | 55,000 | $9.34 | 55,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:32 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 180,000 | $9.34 | 180,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:33 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Melnick David A. Chief Medical Officer | 55,000 | $9.34 | 55,000 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-23 5:33 pm | N/A 2030-06-23 | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 15,000 | $13.94 | 15,000 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,613 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 8,045 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 3,880 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,642 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,613 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 8,045 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 3,880 | $5.9 | 65,817 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,642 | $5.9 | 65,817 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 754 | $5.9 | 65,817 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,293 | $5.9 | 65,817 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 754 | $5.9 | 65,817 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 2,293 | $5.9 | 65,817 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 9:51 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 774 | $5.9 | 65,817 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 9:51 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO | 774 | $5.9 | 65,817 (Direct) | View |